James Lymp
- Hepatology top 0.5%
- Liver Diseases and Immunity 6
- Liver Disease and Transplantation 4
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 8
- Hematology top 1%
-
- CAR-T cell therapy research 13
-
- Lymphoma Diagnosis and Treatment 7
-
- Chronic Lymphocytic Leukemia Research 6
-
- Cystic Fibrosis Research Advances 6
-
- Asthma and respiratory diseases 4
- Co-authors
- Paul AnguloKeith D. LindorSchuyler O. SandersonAriel E. FeldsteinLeon A. AdamsRoshini S. AbrahamJerry A. KatzmannRobert A. Kyle
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
James Lymp
55 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Hepatology 1.5k
- Endocrinology, Diabetes and Metabolism 1.8k
- Epidemiology 3.7k
- Hematology 721
- Critical Care and Intensive Care Medicine 282
Countries citing papers authored by James Lymp
This map shows the geographic impact of James Lymp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lymp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lymp more than expected).
Fields of papers citing papers by James Lymp
This network shows the impact of papers produced by James Lymp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lymp. The network helps show where James Lymp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Lymp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 27 | |
| 3 | 2014 | 80 | |
| 4 | 2013 | 174 | |
| 5 | 2012 | 26 | |
| 6 | 2010 | 21 | |
| 7 | 2010 | 127 | |
| 8 | 2006 | 40 | |
| 9 | 2006 | 113 | |
| 10 | 2005 | 94 | |
| 11 | 2005 | 176 | |
| 12 | 2005 | 32 | |
| 13 | The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Studybreakdown → | 2005 | 2244 |
| 14 | 2005 | 116 | |
| 15 | 2005 | 257 | |
| 16 | 2004 | 141 | |
| 17 | 2004 | 123 | |
| 18 | Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trialbreakdown → | 2004 | 545 |
| 19 | 2004 | 492 | |
| 20 | 2003 | 76 |
About James Lymp
James Lymp is a scholar working on Chemical Health and Safety, Hepatology and Radiological and Ultrasound Technology, having authored 55 papers that have together received 7.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Liver Disease Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Liver Diseases and Immunity (6 papers), Cystic Fibrosis Research Advances (6 papers), Liver Disease and Transplantation (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Hepatology (1.5k citations), Endocrinology, Diabetes and Metabolism (1.8k citations) and Epidemiology (3.7k citations). James Lymp has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul Angulo, Keith D. Lindor, Schuyler O. Sanderson, Ariel E. Feldstein, Leon A. Adams, Roshini S. Abraham, Jerry A. Katzmann, Robert A. Kyle, Sandra C. Bryant and Raynell Clark. Their work appears in journals such as Blood, Journal of Cystic Fibrosis, Hepatology, Clinical Chemistry and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.